DDL 2023

December 7-9 | Edinburgh, Scotland

Proveris is a sponsor, exhibitor, and poster presenter at the Drug Delivery to The Lungs (DDL) conference which will be held December 7-9. 

If you would like to learn more and schedule a meeting with us, email us at contactus@proveris.com.

Drug Delivery to the Lungs (DDL) is an annual conference covering all aspects of respiratory drug delivery. It attracts a wide variety of attendees, including scientists, academics, clinicians, regulators, and industry experts. It offers a venue for lectures, posters, and exhibitions.

Learn more and register HERE.

Rescon Summit

September 28-29 | New York, USA

Proveris is a sponsor and exhibitor at the Rescon Summit which will be held September 28-29. 

If you would like to learn more and schedule a meeting with us, email us at contactus@proveris.com.

Rescon Summit highlights innovations in the respiratory sector and connected devices. The event will showcase new trends in aerosol science and the future directions of inhalation drug delivery research.

Learn more and register HERE.

6th Inhalation China Symposium

July 2022 | China

Proveris Scientific’s partner in China, Ruty Li of Quantaflux, will attend the 6th Inhalation China Symposium. He will be at the Proveris table in the exhibit area and will give a scientific presentation on behalf of Proveris.

If you would like to learn more and schedule a meeting with him, email us at contactus@proveris.com.

Inhalation China Symposium is organized by Fudan University School of Pharmacy, Pharmaceutical Preparation Committee of Shanghai Pharmaceutical Association, and co-organized by Reed Sino Pharma and Shanghai Pharma. Experts from Central CFDA, Local CFDA, technology companies, R&D organizations, universities, and hospitals speak about current topics related to inhalation drug delivery science, applications, and technology.

8th Pulmonary Drug Delivery

May 31-June 2 | Istanbul, Turkey

Proveris is a presenter at the 8th Drug Delivery Workshop which will be held from May 31-June 2.

Our presentation entitled ‘Spray Characterization for In Vitro Bioequivalence’ will be given by Dr. Deborah Jones, EMEA Director of Sales. The presentation focus is on in vitro nasal drug development solutions for the Turkish pharma market and will include new measurements of interest for pMDI and Soft Mist drug development.

If you would like to learn more and schedule a private meeting with us, email us at contactus@proveris.com.

The Pulmonary Drug Delivery Workshop (PDD) series aim is to provide a space for discussions on research and engagement in new collaborations. It’s a forum for learning about inhalation drug delivery from leaders in the field and discuss aerosol-related topics in a relaxed atmosphere. 

Learn more and register HERE.

Novel Formulation & Delivery Summit

May 17-18 | San Diego, USA

Proveris is an expertise sponsor of The Novel Formulation & Delivery Summit which will be held from May 17-18.

Our presentation entitled ‘Using Quality by Design (QbD) to Accelerate Nasal Drug Product Development’ discusses in vitro testing approaches that accommodate the complexity of combination products. The approach incorporates QbD into the very early development phase and facilitates a streamlined scale-up during commercialization.

If you would like to learn more and schedule a private meeting with us, email us at contactus@proveris.com.

The Novel Nasal Formulation & Delivery Summit is a unique forum set to unite 60 plus pioneers in nasal drug development. Speakers will reveal enlightening content focusing on novel formulation and delivery techniques for both acute and chronic disease indications. Attendees will learn how to propel non-invasive therapeutics through nasal drug delivery route and increase patient adherence across the next generations of vaccines, CNS, and respiratory indications.

Learn more and register HERE.

RDD Europe 2023

May 2-5 | Nice, France

Proveris is an exhibitor, workshop presenter, and poster presenter at the Respiratory Drug Delivery (RDD 2023) which will be held in-person and as a virtual event from May 2-5.

Our workshop presentation entitled ‘Synergies of Inhalation Product Development and Spray Characterization’ is in collaboration with Catalent Inhalation. Our poster presentation entitled ‘Comparison of Spray Characteristics of pMDIs with P-134a (current Propellant) and Low-GWP P-152a Propellant with 8% Ethanol and Ethanol-free’ is in collaboration with Koura Global.

If you would like to learn more and schedule a private meeting with us, email us at contactus@proveris.com.

Respiratory Drug Delivery, RDD®, is an international conference for researchers, regulators, business professionals and suppliers active in pulmonary and nasal drug delivery. It provides a venue for expert speakers to cover topics including new therapeutic opportunities, drug delivery technologies, regulatory science, and novel in vitro, in vivo and clinical testing methods.

Learn more and register HERE.

Inhalation Drug Delivery Forum 2023

April 12-13 | Pennsylvania, USA

Proveris is a presenter at Pharma Ed’s Inhalation Drug Delivery Forum which will be held from April 12-13 in-person and as a virtual event.

Our presentation entitled ‘Generic Development of Pressurized Metered Dose Inhalers and Soft Mist Inhalers – Alternative Approach to the Comparative Clinical Endpoint BE Study’ will be given by Ben Okorodudu, Vice President of Sales.

If you would like to learn more and schedule a private meeting with us, email us at contactus@proveris.com.

This two-day conference will bring together specialists from the medical, pharmacological, and health care industries looking to learn the latest technical and engineering advances in respiratory delivery systems for large and small molecule drugs and biologics. 

Learn more and register HERE.